CHMP Backs Trumenba for Meningococcal Disease Prevention CHMP Backs Trumenba for Meningococcal Disease Prevention

The Committee for Medicinal Products for Human Use recommended marketing authorization for Trumenba for immunization against invasive meningococcal disease caused by meningococcal serogroup B bacteria.International Approvals
Source: Medscape Nurses Headlines - Category: Nursing Tags: Infectious Diseases News Alert Source Type: news